Cambridge Healthtech Institute’s 11th Annual
Oligonucleotide Discovery & Delivery
Driving Innovation in Design, Development, and Performance for the Next Wave of Oligonucleotide Therapeutics
March 18-19, 2026
Cambridge Healthtech Institute’s Oligonucleotide Discovery & Delivery conference brings together leading voices from biotech, pharma, and academia to showcase breakthroughs across the discovery-to-development continuum. From novel chemistries and RNA modalities, to emerging delivery platforms and clinical translation, this event provides deep insights into the strategies reshaping oligonucleotide therapeutics. Key sessions will explore case studies across RNA, antisense, GalNAc, conjugates, editing therapies, and more—highlighting innovations that are advancing therapeutic precision, extrahepatic delivery, and patient impact.